SenoRx (SENO) Granted 46th Patent Related to Breast Biopsy
Shares of SenoRx Inc. (Nasdaq: SENO) dropped 21 cents today, or 2 percent, to $9.80 - a continual slide from its all-time high of $11.10 on Monday when the company announced it was granted its third patent for its Multi-Lumen Radiation Balloon Applicator for the treatment of breast cancer.The patent, issued by the U.S. Patent and Trademark Office, is one of 46 patents owned by SenoRx related to breast biopsy, excision devices and radiation balloon products. The medical device maker received FDA clearance to market its Multi-Lumen Radiation Balloon Applicator in May 2007, and expects to ship the device for…